O-Desmethyl Gefitinib,
847949-49-9,
UNII-53LPA3P6SI,
Gefitinib Impurity 11,
53LPA3P6SI,
M523595,
7-Quinazolinol,4-[(3-chloro-4-fluorophenyl)amino]-6-[3-(4-morpholinyl)propoxy]-,
4-((3-Chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol,
O-Desmethylgefitinib,
M-523595,
SCHEMBL19236250,
CTK5F3153,
DTXSID50461102,
CHEBI:143393,
BCP15109,
ZINC22056257,
AKOS030242876,
4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-6-[3-(4-MORPHOLINYL)PROPOXY]-7-QUINAZOLINOL,
7-Quinazolinol,4-((3-chloro-4-fluorophenyl)amino)-6-(3-(4-morpholinyl)propoxy),
RT-014819,
FT-0666129,
4-[(3-Chloro-4-fluorophenyl)amino]-7-hydroxy-6-(3-morpholinopropoxy)quinazoline,
ZD 1839,
CID11281905,
O-Desmethyl gefitinib, 98% - 10MG 10mg,
4-[(3-chloro-4-fluoro-phenyl)amino]-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-7-one,